Exchange: NASDAQ·Updated 05:05 AM EDT
LENZ logo

LENZ LENZ Therapeutics Inc.

$4.93
$0.02
(0.41%)
Pre-Market
Prev Close $4.91
Reported EarningsAug 11
Mkt Cap$167.47M
Vol661.00

About LENZ

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.
35

Bearish Sentiment

How do you feel about LENZ?

Advertisement|Remove ads.